Goldman Sachs’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $9.61M | Buy |
|
|||||
|
2022
Q3 | $476K | Buy |
|
|||||
|
2022
Q2 | $138K | Buy |
|
|||||
|
2022
Q1 | $85K | Sell |
|
|||||
|
2021
Q4 | $1.21M | Sell |
|
|||||
|
2021
Q3 | $1.74M | Sell |
|
|||||
|
2021
Q2 | $2.26M | Buy |
|
|||||
|
2021
Q1 | $319K | Buy |
|
|||||
|
2020
Q4 | $243K | Sell |
|
|||||
|
2020
Q3 | $663K | Buy |
|
|||||
|
2020
Q2 | $374K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $28K | Sell |
|
|||||
|
2019
Q3 | $65K | Sell |
|
|||||
|
2019
Q2 | $236K | Buy |
|
|||||
|
2019
Q1 | $23K | Sell |
|
|||||
|
2018
Q4 | $131K | Buy |
|
|||||
|
2018
Q3 | $231K | Buy |
|
|||||
|
2018
Q2 | $44K | Sell |
|
|||||
|
2018
Q1 | $2.27M | Buy |
|
|||||
|
2017
Q4 | $672K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $30K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $15K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $24K | Sell |
|
|||||
|
2015
Q3 | $91K | Buy |
|
|||||
|
2015
Q2 | $120K | Sell |
|
|||||
|
2015
Q1 | $272K | Buy |
|
|||||
|
2014
Q4 | $116K | Sell |
|
|||||
|
2014
Q3 | $217K | Buy |
|
|||||
|
2014
Q2 | $357K | Sell |
|
|||||
|
2014
Q1 | $329K | Sell |
|
|||||
|
2013
Q4 | $447K | Buy |
|
|||||
|
2013
Q3 | $275K | Buy |
|
|||||
|
2013
Q2 | $217K | Buy |
|